![Seong-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Jin Kim
Algemeen Directeur bij
MEDPACTO, INC.
Vermogen: 6 M $ op 31-08-2026
Profiel
Seong-Jin Kim is the founder of MedPacto, Inc. (2013) as Chief Executive Officer, Director & CTO.
Dr. Kim is the founder of Celloram, Inc. (2018) as Director.
Dr. Kim is currently the Head-Cancer Institute at CHA University.
Formerly, Dr. Kim served as Independent Director, Head-Research & Development at THERAGEN ETEX Co., Ltd. Education includes a doctorate from the University of Tsukuba.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MEDPACTO, INC. 6,36% | 15-03-2025 | 2.181.216 ( 6,36% ) | 4 M $ | 31-08-2026 |
| 15-03-2025 | 1.059.025 ( 2,85% ) | 2 M $ | 31-08-2026 |
Actieve functies van Seong-Jin Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDPACTO, INC. | Algemeen Directeur | 19-06-2013 |
CHA University
 CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-07-2011 |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Oprichter | 01-01-2018 |
Eerdere bekende functies van Seong-Jin Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Seong-Jin Kim
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
18
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Tsukuba
 University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
THERAGEN ETEX Co., Ltd.
 THERAGEN ETEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
CHA University
CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Health Technology |
